| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 7.02% | 1,947,968 | $750,279,355 | -28,050 | -1.42% | Form 4 | |
| ARGX | argenx SE | 0.19% | 37,760 | $20,814,067 | -40,000 | -51.44% | $551.22 | 13F |
| CERS | Cerus Corporation | 0.17% | 12,883,844 | $18,166,220 | -6,467,243 | -33.42% | $1.41 | 13F |
| AKRO | Akero Therapeutics, Inc. | 0.16% | 324,630 | $17,322,257 | -224,083 | -40.84% | $53.36 | 13F |
| NGNE | Neurogene Inc. | 0.14% | 991,691 | $14,825,780 | -494,509 | -33.27% | $14.95 | 13F |
| DSGN | Design Therapeutics, Inc. | 0.05% | 1,712,882 | $5,772,412 | -30,843 | -1.77% | $3.37 | 13F |
| FATE | Fate Therapeutics, Inc. | 0.03% | 2,485,018 | $2,783,220 | -773,384 | -23.74% | $1.12 | 13F |
| CADL | Candel Therapeutics, Inc. | 0.02% | 355,112 | $1,796,867 | -2,082,077 | -85.43% | $5.06 | 13F |
| RCKT | Rocket Pharmaceuticals, Inc. | 0.01% | 552,079 | $1,352,594 | -545,000 | -49.68% | $2.45 | 13F |